Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Corvus Pharmaceuticals (CRVS) Other Gross PP&E Adjustments: 2022-2025

Historic Other Gross PP&E Adjustments for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to $1.7 million.

  • Corvus Pharmaceuticals' Other Gross PP&E Adjustments fell 59.72% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year decrease of 19.21%. This contributed to the annual value of $3.3 million for FY2024, which is 258.89% up from last year.
  • Corvus Pharmaceuticals' Other Gross PP&E Adjustments amounted to $1.7 million in Q3 2025, which was up 16.33% from $1.5 million recorded in Q2 2025.
  • Corvus Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $4.2 million for Q3 2024, and its period low was -$2.8 million during Q4 2022.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was $3.0 million (2023), whereas its average is $2.4 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 258.89% in 2024, then plummeted by 66.29% in 2025.
  • Over the past 4 years, Corvus Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$2.8 million in 2022, then grew by 25.17% to -$2.1 million in 2023, then skyrocketed by 258.89% to $3.3 million in 2024, then crashed by 59.72% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.5 million for Q2 2025, and $1.2 million during Q1 2025.